Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Arthur, Charles R ^a   Morton, Stephanie L ^a   Dunham, Lisa D ^a   Keeney, Paula M ^a   Bennett Jr , James P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 OXYGUANOSINE GLYCOSYLASE; DNA GLYCOSYLTRANSFERASE; MESSENGER RNA; MITOCHONDRIAL DNA; MULTIENZYME COMPLEX; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN MITOCHONDRION; DNA DAMAGE; FRONTAL CORTEX; GENE MUTATION; HETEROPLASMY; HUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION;

EID: 70350335328     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-37     Document Type: Article

References (43)

1. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. D Aarsland R Perry A Brown JP Larsen C Ballard, Ann Neurol 2005 58 5 773 776 10.1002/ana.20635 16240351 (Pubitemid 41552553)
2. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia. E Bertrand W Lechowicz GM Szpak E Lewandowska J Dymecki T Wierzba-Bobrowicz, Folia Neuropathol 2004 42 3 141 150 15535032
3. alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei. E Braak D Sandmann-Keil U Rub WP Gai RA de Vos EN Steur K Arai H Braak, Acta Neuropathol (Berl) 2001 101 3 195 201
4. Staging of brain pathology related to sporadic Parkinson's disease. H Braak K Del Tredici U Rub RA de Vos EN Jansen Steur E Braak, Neurobiol Aging 2003 24 2 197 211 10.1016/S0197-4580(02)00065-9 12498954
5. Stages in the development of Parkinson's disease-related pathology. H Braak E Ghebremedhin U Rub H Bratzke K Del Tredici, Cell Tissue Res 2004 318 1 121 134 10.1007/s00441-004-0956-9 15338272
6. Where does parkinson disease pathology begin in the brain? K Del Tredici U Rub RA De Vos JR Bohl H Braak, J Neuropathol Exp Neurol 2002 61 5 413 426 12030260
7. Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects. I Ferrer, Prog Neurobiol 2009 88 2 89 103 10.1016/j.pneurobio.2009.02.004 19482226
8. Cognitive and behavioural impairment in Parkinson's disease. D Merims M Freedman, Int Rev Psychiatry 2008 20 4 364 373 10.1080/09540260802095123 18925485
9. Parkinson's disease. AJ Lees J Hardy T Revesz, Lancet 2009 373 9680 2055 2066 10.1016/S0140-6736(09)60492-X 19524782
10. Neurobiology and treatment of Parkinson's disease. AH Schapira, Trends Pharmacol Sci 2009 30 1 41 47 10.1016/j.tips.2008.10.005 19042040
11. Parkinson's disease: from monogenic forms to genetic susceptibility factors. S Lesage A Brice, Human molecular genetics 2009 18 R1 48 59 10.1093/hmg/ddp012 19297401
12. What causes cell death in Parkinson's disease? A Gupta VL Dawson TM Dawson, Ann Neurol 2008 64 Suppl 2 3 15 19127586
13. Value of genetic models in understanding the cause and mechanisms of Parkinson's disease. DJ Moore TM Dawson, Curr Neurol Neurosci Rep 2008 8 4 288 296 10.1007/s11910-008-0045-7 18590612
14. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. C Zhou Y Huang S Przedborski, Ann N Y Acad Sci 2008 1147 93 104 19076434
15. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. C Henchcliffe MF Beal, Nat Clin Pract Neurol 2008 4 11 600 609 10.1038/ncpneuro0924 18978800
16. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. R Betarbet TB Sherer G MacKenzie M Garcia-Osuna AV Panov JT Greenamyre, Nat Neurosci 2000 3 12 1301 1306 10.1038/81834 11100151
17. Complex I and Parkinson's disease. JT Greenamyre TB Sherer R Betarbet AV Panov, IUBMB Life 2001 52 3-5 135 141 10.1080/15216540152845939 11798025
18. Mechanism of toxicity in rotenone models of Parkinson's disease. TB Sherer R Betarbet CM Testa BB Seo JR Richardson JH Kim GW Miller T Yagi A Matsuno-Yagi JT Greenamyre, J Neurosci 2003 23 34 10756 10764 14645467 (Pubitemid 37499681)
19. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease. M Marella BB Seo E Nakamaru-Ogiso JT Greenamyre A Matsuno-Yagi T Yagi, PLoS One 2008 3 1 1433 10.1371/journal.pone.0001433 18197244
20. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. PM Keeney J Xie RA Capaldi JP Bennett Jr, J Neurosci 2006 26 19 5256 5264 10.1523/JNEUROSCI.0984- 06.2006 16687518
21. Respiratory active mitochondrial supercomplexes. R Acin-Perez P Fernandez-Silva ML Peleato A Perez-Martos JA Enriquez, Molecular cell 2008 32 4 529 539 10.1016/j.molcel.2008.10.021 19026783
22. Significance of respirasomes for the assembly/stability of human respiratory chain complex I. H Schagger R de Coo MF Bauer S Hofmann C Godinot U Brandt, The Journal of biological chemistry 2004 279 35 36349 36353 10.1074/jbc.M404033200 15208329
23. Surveyor Nuclease: a new strategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects. S Bannwarth V Procaccio V Paquis-Flucklinger, Human mutation 2005 25 6 575 582 10.1002/humu.20177 15880407
24. Rapid identification of unknown heteroplasmic mutations across the entire human mitochondrial genome with mismatch-specific Surveyor Nuclease. S Bannwarth V Procaccio V Paquis-Flucklinger, Nature protocols 2006 1 4 2037 2047 10.1038/nprot.2006.318 17487193
25. Oxidative damage in nucleic acids and Parkinson's disease. Y Nakabeppu D Tsuchimoto H Yamaguchi K Sakumi, J Neurosci Res 2007 85 5 919 934 10.1002/jnr.21191 17279544
26. The progression of Parkinson disease: a hypothesis. AE Lang, Neurology 2007 68 12 948 952 10.1212/01.wnl.0000257110.91041.5d 17372132
27. Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease. AE Lang JA Obeso, Ann Neurol 2004 55 6 761 765 10.1002/ana.20102 15174009
28. Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues. MK Borland KP Mohanakumar JD Rubinstein PM Keeney J Xie R Capaldi LD Dunham PA Trimmer JP Bennett Jr, Biochim Biophys Acta 2009 1792 1 68 74 18973805
29. Subunits of mitochondrial complex I exist as part of matrix- and membrane-associated subcomplexes in living cells. CE Dieteren PH Willems RO Vogel HG Swarts J Fransen R Roepman G Crienen JA Smeitink LG Nijtmans WJ Koopman, The Journal of biological chemistry 2008 283 50 34753 34761 10.1074/jbc.M807323200 18826940
30. Identification of mitochondrial complex I assembly intermediates by tracing tagged NDUFS3 demonstrates the entry point of mitochondrial subunits. RO Vogel CE Dieteren LP van den Heuvel PH Willems JA Smeitink WJ Koopman LG Nijtmans, The Journal of biological chemistry 2007 282 10 7582 7590 10.1074/jbc.M609410200 17209039
31. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Murray SW Taylor B Zhang SS Ghosh RA Capaldi, The Journal of biological chemistry 2003 278 39 37223 37230 10.1074/jbc.M305694200 12857734
32. Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns. RH Triepels BJ Hanson LP van den Heuvel L Sundell MF Marusich JA Smeitink RA Capaldi, The Journal of biological chemistry 2001 276 12 8892 8897 10.1074/jbc.M009903200 11112787
33. Transcriptional mutagenesis induced by uracil and 8-oxoguanine in Escherichia coli. D Bregeon ZA Doddridge HJ You B Weiss PW Doetsch, Molecular cell 2003 12 4 959 970 10.1016/S1097-2765(03)00360-5 14580346
34. Assays for transcriptional mutagenesis in active genes. D Bregeon PW Doetsch, Methods Enzymol 2006 409 345 357 10.1016/S0076-6879(05)09020-8 16793411
35. Comparative analysis of 8-oxoG:C, 8-oxoG:A, A:C and C:C DNA repair in extracts from wild type or 8-oxoG DNA glycosylase deficient mammalian and bacterial cells. F Dantzer M Bjoras L Luna A Klungland E Seeberg, DNA Repair (Amst) 2003 2 6 707 718 12767349
36. Repair and mutagenic potency of 8-oxoG:A and 8-oxoG:C base pairs in mammalian cells. F Le Page A Guy J Cadet A Sarasin A Gentil, Nucleic Acids Res 1998 26 5 1276 1281 10.1093/nar/26.5.1276 9469837
37. Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase. GW Hsu M Ober T Carell LS Beese, Nature 2004 431 7005 217 221 10.1038/nature02908 15322558
38. Mitochondrial DNA 4977 bp deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer's disease patients. AM Lezza P Mecocci A Cormio MF Beal A Cherubini P Cantatore U Senin MN Gadaleta, FASEB J 1999 13 9 1083 1088 10336891
39. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. ZI Alam A Jenner SE Daniel AJ Lees N Cairns CD Marsden P Jenner B Halliwell, J Neurochem 1997 69 3 1196 1203 9282943
40. Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders. J Fukae M Takanashi S Kubo K Nishioka Y Nakabeppu H Mori Y Mizuno N Hattori, Acta Neuropathol 2005 109 3 256 262 10.1007/s00401-004-0937-9 15841414
41. Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease. T Arai J Fukae T Hatano S Kubo T Ohtsubo Y Nakabeppu H Mori Y Mizuno N Hattori, Acta Neuropathol 2006 112 2 139 145 10.1007/s00401-006-0081-9 16773329
42. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. J Zhang G Perry MA Smith D Robertson SJ Olson DG Graham TJ Montine, The American journal of pathology 1999 154 5 1423 1429 10329595
43. Mitochondrial Gene Therapy Augments Mitochondrial Physiology in a Parkinson's Disease Cell Model. PM Keeney CK Quigley LD Dunham CM Papageorge S Iyer RR Thomas KM Schwarz PA Trimmer SM Khan FR Portell, et al. Hum Gene Ther 2009 19374590